Form 4: Guardant Health Director Tariq Musa Reports Acquisition of Over 6,900 Shares Through RSU Conversions
Insider Transaction Report
Guardant Health Director Tariq Musa has reported the acquisition of 6,924 shares of common stock through the conversion of Restricted Stock Units (RSUs) in two separate transactions in mid-June 2025, increasing his direct beneficial ownership to 10,403 shares.
Summary
- Tariq Musa, a Director at Guardant Health, Inc. (GH), acquired a total of 6,924 shares of common stock through the conversion of Restricted Stock Units (RSUs).
- On June 12, 2025, Mr. Musa acquired 6,674 shares of common stock at a price of $0 per share, resulting from the conversion of RSUs.
- These RSUs were granted on June 12, 2024, and vested on their one-year anniversary or the date of the next annual stockholders meeting, whichever was earlier.
- Following this transaction, Mr. Musa's direct beneficial ownership of common stock increased to 10,153 shares.
- On June 15, 2025, Mr. Musa acquired an additional 250 shares of common stock at a price of $0 per share, also from the conversion of RSUs.
- These RSUs were granted on March 6, 2023, with 25% vesting on March 15, 2023, and the remainder vesting monthly over the subsequent three years.
- After this second transaction, Mr. Musa's total direct beneficial ownership of common stock reached 10,403 shares.
Sentiment
Score: 7
Explanation: The sentiment is positive as a director increased their beneficial ownership through the conversion of equity awards, aligning their interests with shareholders. This is a routine, expected event for equity compensation.
Positives
- Director Tariq Musa increased his direct beneficial ownership in Guardant Health, Inc. by acquiring 6,924 shares of common stock.
- The acquisitions were through the conversion of Restricted Stock Units (RSUs), indicating the vesting of previously granted equity compensation.
- The increase in insider ownership can be viewed positively by investors as it aligns management's interests with shareholders.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Tariq Musa, a Director of Guardant Health, Inc., acquired 6,924 shares of common stock through the conversion of Restricted Stock Units (RSUs) as part of his equity compensation, which is a standard related-party transaction for executive and director compensation.
Stakeholder Impact
- Shareholders: The increase in director ownership may be viewed positively as it aligns the interests of management with those of shareholders, potentially signaling confidence in the company's future.
- Employees: The vesting of RSUs is a common form of equity compensation, which can be a positive for employee retention and motivation if similar plans are in place for other employees.
- Company: The transactions represent the fulfillment of equity compensation obligations, which is a routine part of managing executive and director incentives.
Key Dates
| Date | Description |
|---|---|
| 2023-03-06 | Grant date for Restricted Stock Units, 250 of which vested on March 15, 2023, with the remainder vesting monthly over three years. |
| 2023-03-15 | Vesting date for 25% of Restricted Stock Units granted on March 6, 2023. |
| 2024-06-12 | Grant date for Restricted Stock Units, 6,674 of which vested on their one-year anniversary or the date of the next annual stockholders meeting, whichever was earlier. |
| 2025-06-12 | Transaction date: Acquisition of 6,674 shares of common stock by Tariq Musa through RSU conversion. |
| 2025-06-15 | Transaction date: Acquisition of 250 shares of common stock by Tariq Musa through RSU conversion. |
| 2025-06-16 | Date the Form 4 filing was signed by John G. Saia, attorney-in-fact for Musa Tariq. |
Recommendation
holdKeywords
Guardant Health, GH, Tariq Musa, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Beneficial Ownership, Director, Equity Compensation, Stock Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.